NDC 42747-761 – Poteligeo
Mogamulizumab 4 mg/mL · Injection · Intravenous
Product NDC42747-761
Product details
- Brand name
- Poteligeo
- Generic name
- Mogamulizumab-kpkc
- Labeler
- Kyowa Kirin, Inc.
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- BLA · BLA761051
- Marketed since
- August 8, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- Chemokine Receptor Type 4 Interaction; Monoclonal Antibody
Active ingredients
- Mogamulizumab 4 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 42747-761-01 | 1 VIAL, GLASS in 1 CARTON (42747-761-01) / 5 mL in 1 VIAL, GLASS | Aug 8, 2018 |